Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model

  • Telbivudine therapy for chronic hepatitis B
  • Jia-Horng Kao, Tarik Asselah, Xiao-Guang Dou, Kamal Hamed
  • Journal of Gastroenterology and Hepatology, January 2017, Wiley
  • DOI: 10.1111/jgh.13512

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/jgh.13512

The following have contributed to this page: Dr Kamal Hamed